Did you make it #MRRT2022? We had a great time in Manchester yesterday hearing from a range of contributors on advances in MRI for radiotherapy. Don't feel left out though... Come along to #ROBRT2022 in London on June 16th when we'll be looking at plan robustness for RT.
Christopher Moore explained a study which looked at adc values measured on the #unity linac for prostate patients over the course of treatment. No significant differences were seen in long course treatments or sabr #MRRT2022
Dr Petra van Houdt explained the imaging biomarker studies being done at the Netherlands Cancer Institute. She presented the talk remotely and answered questions over teams.